References
- Fleischmann-Struzek C, Goldfarb DM, Schlattmann P, Schlapbach LJ, Reinhart K, Kissoon N. The global burden of paediatric and neonatal sepsis: a systematic review. Lancet Respir Med. 2018 Mar;6(3):223–30.
- Maddaloni C, De Rose DU, Santisi A, Martini L, Caoci S, Bersani I, et al. The Emerging Role of Presepsin (P-SEP) in the Diagnosis of Sepsis in the Critically Ill Infant: A Literature Review. Int J Mol Sci. 2021 Nov 10;22(22):12154.
- Milton R, Gillespie D, Dyer C, Taiyari K, Carvalho MJ, Thomson K, et al. Neonatal sepsis and mortality in low-income and middle-income countries from a facility-based birth cohort: an international multisite prospective observational study. Lancet Glob Health. 2022 May 1;10(5):e661–72.
- Kosmeri C, Giapros V, Serbis A, Baltogianni M. Application of Advanced Molecular Methods to Study Early-Onset Neonatal Sepsis. Int J Mol Sci. 2024 Feb 13;25(4):2258.
- Murthy S, Godinho MA, Guddattu V, Lewis LES, Nair NS. Risk factors of neonatal sepsis in India: A systematic review and meta-analysis. PLoS ONE. 2019 Apr 25;14(4):e0215683.
- Ng PC. Diagnostic markers of infection in neonates. Arch Dis Child Fetal Neonatal Ed. 2004 May;89(3):F229-235.
- Bellos I, Fitrou G, Pergialiotis V, Thomakos N, Perrea DN, Daskalakis G. The diagnostic accuracy of presepsin in neonatal sepsis: a meta-analysis. Eur J Pediatr. 2018 May;177(5):625–32.
- Sourour W, Sanchez V, Sourour M, Burdine J, Lien ER, Nguyen D, et al. The Association between Prolonged Antibiotic Use in Culture Negative Infants and Length of Hospital Stay and Total Hospital Costs. Am J Perinatol. 2023 Apr;40(5):525–31.
- Catassi G, Mateo SG, Occhionero AS, Esposito C, Giorgio V, Aloi M, et al. The importance of gut microbiome in the perinatal period. Eur J Pediatr. 2024;183(12):5085–101.
- Pammi M, Flores A, Versalovic J, Leeflang MM. Molecular assays for the diagnosis of sepsis in neonates. Cochrane Database Syst Rev. 2017 Feb 25;2017(2):CD011926.
- Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum Procalcitonin and C-Reactive Protein Levels as Markers of Bacterial Infection: A Systematic Review and Meta-analysis. Clin Infect Dis. 2004 Jul 15;39(2):206–17.
- Fleiss N, Shabanova V, Murray TS, Gallagher PG, Bizzarro MJ. The diagnostic utility of obtaining two blood cultures for the diagnosis of early onset sepsis in neonates. J Perinatol. 2024 May;44(5):745–7.
- Ruan L, Chen GY, Liu Z, Zhao Y, Xu GY, Li SF, et al. The combination of procalcitonin and C-reactive protein or presepsin alone improves the accuracy of diagnosis of neonatal sepsis: a meta-analysis and systematic review. Crit Care Lond Engl. 2018 Nov 21;22(1):316.
- Pietrasanta C, Ronchi A, Vener C, Poggi C, Ballerini C, Testa L, et al. Presepsin (Soluble CD14 Subtype) as an Early Marker of Neonatal Sepsis and Septic Shock: A Prospective Diagnostic Trial. Antibiot Basel Switz. 2021 May 14;10(5):580.
- Botondi V, D’Adamo E, Plebani M, Trubiani O, Perrotta M, Di Ricco L, et al. Perinatal presepsin assessment: a new sepsis diagnostic tool? Clin Chem Lab Med. 2022 Jul 26;60(8):1136–44.
- Hayes R, Hartnett J, Semova G, Murray C, Murphy K, Carroll L, et al. Correction: Neonatal sepsis definitions from randomised clinical trials. Pediatr Res. 2024 Dec;96(7):1882.
- Rossum A van, Wulkan RW, Oudesluys-Murphy AM. Procalcitonin as an early marker of infection in neonates and children. Lancet Infect Dis. 2004 Oct 1;4(10):620–30.
- Weitkamp JH, Aschner JL. Diagnostic Use of C-Reactive Protein (CRP) in Assessment of Neonatal Sepsis. NeoReviews. 2005 Nov 1; 6(11): e508–15.
- Endo S, Suzuki Y, Takahashi G, Shozushima T, Ishikura H, Murai A, et al. Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study. J Infect Chemother. 2012 Jan 1;18(6):891–7.
- Poggi C, Lucenteforte E, Petri D, De Masi S, Dani C. Presepsin for the Diagnosis of Neonatal Early-Onset Sepsis: A Systematic Review and Meta-analysis. JAMA Pediatr. 2022 Aug 1;176(8):750–8.
- Chenevier-Gobeaux C, Borderie D, Weiss N, Mallet-Coste T, Claessens YE. Presepsin (sCD14-ST), an innate immune response marker in sepsis. Clin Chim Acta Int J Clin Chem. 2015 Oct 23;450:97–103.
- Rello J, Alonso-Tarrés C. Emerging Technologies for Microbiologic Diagnosis of Sepsis: The Rapid Determination of Resistance to Antimicrobial Agents Should Be the Key. Clin Infect Dis. 2021 Oct 1;73(7):1173–5.